Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Syfovre Side Effects Linked to Eye Inflammation, Vision Loss Problems, Ophthalmologists Warn Warning letter indicates that Syfovre has been linked to side effects similar to the other eye medication Beovu, including reports of eye inflammation, vision loss and even blindness July 20, 2023 Irvin Jackson Add Your Comments A group of retinal specialists are warning that the side effects of Syfovre, a recently approved eye medication, may be linked to an increased risk of inflammation that could cause blindness in some cases. Syfovre (Pegcetacoplan injection) was introduced by the drug maker Apellis Pharmaceuticals in February 2023, following approval by the FDA for treatment of geographic atrophy, which is a common form of vision loss. However, as the medication is increasingly used by patients, some are reporting serious problems from Syfovre, which may not have been adequately disclosed by the drug maker. Earlier this month, the American Society of Retinal Specialists (ASRS) sent a letter to other healthcare providers, warning that Syfovre has been linked to at least six cases of occlusive retinal vasculitis, which is a serious condition that blocks the flow of blood to the retina and can lead to eye inflammation or complete loss of vision. Syfovre Eye Inflammation Problems According to a report by BioPharma Dive, the ASRS letter warns that eye inflammation side effects from Syfovre appear to occur within one to two weeks after a patient has received their first injection of the medication, which is typically administered every one to two months. The ASRS noted that the Syfovre eye inflammation problems did not appear to be linked to a specific batch of the drug, and indicated it was unclear what was causing the side effects. However, the group of retinal specialists urged healthcare providers to be vigilant, provide close follow-up to patients who recently received a Syfovre injection, and urged doctors and patients to report any adverse events to the FDA. Apellis officials have said they are in the process of investigating the incidents. Similar Beovu Inflammation Warning The ASRS issued a similar warning regarding the age-related macular degeneration drug Beovu in February 2020, after at least 14 cases of retinal vasculitis related to the Beovu eye medication. As a result of the drug makers’ failure to warn about this potential side effect, a number Beovu lawsuits were pursued individuals who experienced problems. Learn More About Beovu Lawsuit Side effects of Beovu have been linked to reports of severe and permanent vision problems, known as retinal vasculitis. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Beovu Lawsuit Side effects of Beovu have been linked to reports of severe and permanent vision problems, known as retinal vasculitis. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Beovu (brolucizumab) was just approved just four years ago, as part of a class of medications known as anti-vascular endothelial growth factor therapy, or anti-VEGF. The FDA required a label update in 2020, in the wake of the ASRS warning, adding new information for users and the medical community about the risk of retinal vasculitis, which can result in blurry vision, visual floaters, dark spots, difficulty distinguishing colors and distorted images. Due to the problems, some doctors decided to stop carrying the eye drug in their inventories and the FDA required the manufacturer to add new warnings about the link between Beovu and retinal vasculitis, and the importance of seeking immediate care from an ophthalmologist if a users’ eyes become red, sensitive to light, painful, or develop changes in vision. The warning and label changes sparked a number of Beovu eye inflammation lawsuits, which have been filed in federal courts nationwide. Tags: Apellis Pharmaceuticals, Beovu, Blindness, Eye Inflammation, Injection, Syfovre, Vision Loss More Beovu Lawsuit Stories Beovu Injection Caused Retinal Vasculitis and Other Vision Side Effects, Lawsuit Alleges December 14, 2022 Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss September 30, 2022 Beovu Injection Lawsuit Over Retinal Injury, Blindness Cleared To Proceed September 28, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: yesterday) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025) 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: 2 days ago) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 5 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Beovu Injection Caused Retinal Vasculitis and Other Vision Side Effects, Lawsuit Alleges December 14, 2022
Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss September 30, 2022
Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: yesterday) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: 2 days ago) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 5 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)